PAPER Lee S, Hahn C, Seong E, Choi HS

Corrigendum to "Reactive EEG biomarkers for diagnosis and prognosis of Alzheimer's disease and mild cognitive impairment" [Biosens. Bioelectron. 273 (2025) 117181].

Biosens Bioelectron. 2025 Mar 7;:117348. Epub 2025 Mar 7 PubMed. Corrected paper.

PAPER Rahman AU, Ali S, Saqia B, Halim Z, Al-Khasawneh MA, AlHammadi DA, Khan MZ, Ullah I, Alharbi M

Alzheimer's Disease Prediction Using 3D-CNNs: Intelligent Processing of Neuroimaging Data.

SLAS Technol. 2025 Mar 6;32:100265. Epub 2025 Mar 6 PubMed.

PAPER Xu C

Enhanced social interaction protects cognition by preserving synapse numbers.

Brain Res. 2025 Mar 6;1854:149552. Epub 2025 Mar 6 PubMed.

PAPER Mielke MM, Fielding RA, Atkinson EJ, Aversa Z, Schafer MJ, Cummings SR, Pahor M, Leeuwenburgh C, LeBrasseur NK

Biomarkers of cellular senescence predict risk of mild cognitive impairment: Results from the lifestyle interventions for elders (LIFE) study.

J Nutr Health Aging. 2025 Mar 7;29(5):100529. Epub 2025 Mar 7 PubMed.

PAPER Gong Y, Chen H, Gu Y, Shen J, Shen T, Ding Y, Lu M, Huang L, Yan M, Song P, Zhu Y, Rong S, Yuan C

Healthy dietary patterns in relation to cognitive performance and Alzheimer's disease mortality.

J Prev Alzheimers Dis. 2025 Mar 6;:100100. Epub 2025 Mar 6 PubMed.

PAPER Veljanoska E, Gomes S, Szende A, Cabra A, Munter-Young R, Gordois A

The Value of Positron Emission Tomography for Confirmation of Alzheimer's Disease in the Era of Amyloid-Targeting Therapies.

Value Health. 2025 Mar 5; Epub 2025 Mar 5 PubMed.

PAPER Zheng M

Snapshot of disease continuum centered on Alzheimer's disease: Exploring modifiable risk factors.

Prog Neuropsychopharmacol Biol Psychiatry. 2025 Mar 5;138:111316. Epub 2025 Mar 5 PubMed.

PAPER Chen H, Fang Z, Lin SL, Schachner M

L1CAM mimetic compound duloxetine improves cognitive impairment in 5xFAD mice and protects Aβ1-42-damaged HT22 cells.

Eur J Pharmacol. 2025 Mar 6;997:177476. Epub 2025 Mar 6 PubMed.

PAPER Elliott C, Jackson J, Findlay J, Williams G, Ghosh A, Ribe E, Ulmschneider M, Khan A, Ballard C, Aarsland D, Baillie GS, Harte M, Killick R

Blocking the Dkk1-LRP6 interaction prevents acute amyloid-β-driven cognitive impairment.

Cell Signal. 2025 Mar 6;131:111716. Epub 2025 Mar 6 PubMed.

PAPER Shahid F, Khan R, Mehmood A, Smadi AA, Ibrahim MM, Zheng Z

A Comprehensive Approach to Anticipating the Progression of Mild Cognitive Impairment.

Brain Res. 2025 Mar 6;:149549. Epub 2025 Mar 6 PubMed.

PAPER Kicik A, Kurt E, Hari E, Ulasoglu-Yildiz Ç, Gurvit H, Demiralp T

Impact of amygdala functional connectivity on cognitive impairment in Alzheimer's disease.

Neurol Sci. 2025 Mar 8; Epub 2025 Mar 8 PubMed.

PAPER Yu J, Zhou R, Liu S, Zheng J, Yan H, Su S, Chai N, Segal E, Jiang C, Guo K, Li CZ

Electrochemical Biosensors for the Detection of Exosomal microRNA Biomarkers for Early Diagnosis of Neurodegenerative Diseases.

Anal Chem. 2025 Mar 9; Epub 2025 Mar 9 PubMed.

PAPER Mitra J, Kodavati M, Dharmalingam P, Guerrero EN, Rao KS, Garruto RM, Hegde ML

Endogenous TDP-43 mislocalization in a novel knock-in mouse model reveals DNA repair impairment, inflammation, and neuronal senescence.

Acta Neuropathol Commun. 2025 Mar 8;13(1):54. PubMed.

PAPER Vostrý M, Chytrý V, Cmorej PC, Fleischmann O, Kubová N

Effect of combined and intensive rehabilitation on cognitive function in patients with Alzheimer's disease evaluated through a randomized controlled trial.

Sci Rep. 2025 Mar 8;15(1):8110. PubMed.

PAPER Guo J, Wang P, Gong J, Sun W, Han X, Xu C, Shan A, Wang X, Luan H, Li S, Li R, Wen B, Chen R, Lv S, Wei C

The disease burden, risk factors and future predictions of Alzheimer's disease and other types of dementia in Asia from 1990 to 2021.

J Prev Alzheimers Dis. 2025 Mar 7;:100122. Epub 2025 Mar 7 PubMed.